David Delaney - 17 Oct 2022 Form 4 Insider Report for Pasithea Therapeutics Corp. (KTTA)

Role
Member of 10% owner group
Signature
/s/ David Delaney
Issuer symbol
KTTA
Transactions as of
17 Oct 2022
Net transactions value
+$1,110
Form type
4
Filing time
19 Oct 2022, 17:29:22 UTC
Previous filing
16 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KTTA Common Stock Purchase $1,110 +1,000 +0.44% $1.11 227,521 17 Oct 2022 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were purchased by Elderhill Corporation, of which David Delaney serves as sole director and President.
F2 191,321 shares are held by Concord IP2, Ltd., of which David Delaney serves as sole director and President, and 36,200 shares are held by Elderhill Corporation.